HOOK (HOOKIPA Pharma) חוב לטווח קצר להון

The financial stability of HOOKIPA Pharma Inc. (HOOK) depends on the support of key investors and research and development costs. The company's technological foundation relies on its own laboratories in the US and Austria, which collaborate with industry leaders. This price chart on GURU.Markets shows the 0.00 metric, supplementing data on the creation of innovative vaccines to combat dangerous infections and malignant tumors.

HOOKIPA Pharma Inc. (HOOK) requires significant working capital to develop innovative immunotherapeutic drugs; therefore, this ratio, which measures the share of liabilities maturing within one year relative to equity, serves as an indicator of operational liquidity and financial stability. A decrease in this metric minimizes default risk but may signal a slowdown in expansion, making the trend of short-term loans relative to equity a key tool for assessing the company's readiness for product commercialization.